FI69753C - Foerfarande foer framstaellning av en salva pao basis av isosorbiddinitrat - Google Patents

Foerfarande foer framstaellning av en salva pao basis av isosorbiddinitrat Download PDF

Info

Publication number
FI69753C
FI69753C FI794003A FI794003A FI69753C FI 69753 C FI69753 C FI 69753C FI 794003 A FI794003 A FI 794003A FI 794003 A FI794003 A FI 794003A FI 69753 C FI69753 C FI 69753C
Authority
FI
Finland
Prior art keywords
isosorbide dinitrate
water
weight
solvent
ointment
Prior art date
Application number
FI794003A
Other languages
English (en)
Finnish (fi)
Other versions
FI69753B (fi
FI794003A (fi
Inventor
Guenter Cordes
Ewald Giesselmann
Ulrich Muench
Original Assignee
Sanol Arznei Schwarz Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanol Arznei Schwarz Gmbh filed Critical Sanol Arznei Schwarz Gmbh
Publication of FI794003A publication Critical patent/FI794003A/fi
Application granted granted Critical
Publication of FI69753B publication Critical patent/FI69753B/fi
Publication of FI69753C publication Critical patent/FI69753C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
FI794003A 1979-06-13 1979-12-20 Foerfarande foer framstaellning av en salva pao basis av isosorbiddinitrat FI69753C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2924005A DE2924005C2 (de) 1979-06-13 1979-06-13 Isosorbiddinitrat enthaltendes Mittel
DE2924005 1979-06-13

Publications (3)

Publication Number Publication Date
FI794003A FI794003A (fi) 1980-12-14
FI69753B FI69753B (fi) 1985-12-31
FI69753C true FI69753C (fi) 1986-05-26

Family

ID=6073179

Family Applications (1)

Application Number Title Priority Date Filing Date
FI794003A FI69753C (fi) 1979-06-13 1979-12-20 Foerfarande foer framstaellning av en salva pao basis av isosorbiddinitrat

Country Status (24)

Country Link
US (1) US4293565A (de)
JP (1) JPS55167216A (de)
AR (1) AR222527A1 (de)
AT (1) AT365451B (de)
AU (1) AU530739B2 (de)
BE (1) BE881382A (de)
CA (1) CA1118351A (de)
CH (1) CH643456A5 (de)
DE (1) DE2924005C2 (de)
DK (1) DK528879A (de)
ES (1) ES8100883A1 (de)
FI (1) FI69753C (de)
FR (1) FR2458285A1 (de)
GB (1) GB2050827B (de)
GR (1) GR70373B (de)
IE (1) IE49527B1 (de)
IT (1) IT1140521B (de)
LU (1) LU81902A1 (de)
NL (1) NL8000129A (de)
NO (1) NO801710L (de)
PT (1) PT70696A (de)
SE (1) SE442266B (de)
YU (1) YU308379A (de)
ZA (1) ZA796256B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK243084A (da) * 1983-05-26 1984-11-27 Takeda Chemical Industries Ltd Perkutane farmaceutiske praeparater til udvortes brug
DE3325466A1 (de) * 1983-07-14 1985-01-24 Mack Chem Pharm Pharmazeutische zubereitung enthaltend isosorbiddinitrat
US4632937A (en) * 1984-12-21 1986-12-30 Ici Americas Dentifrice formulation and method of treating teeth, mouth and throat therewith to reduce plaque accumulation and irritation
DE3613187A1 (de) * 1986-04-18 1987-10-22 Mack Chem Pharm Verwendung einer carbonsaeure in zur topischen anwendung bestimmten pharmazeutischen zubereitungen
US5227157A (en) * 1986-10-14 1993-07-13 Board Of Regents, The University Of Texas System Delivery of therapeutic agents
US4804541A (en) * 1987-08-11 1989-02-14 Moleculon, Inc. Transdermal administration using benzyl alcohol
US4959208A (en) * 1987-10-19 1990-09-25 Ppg Industries, Inc. Active agent delivery device
US5035886A (en) * 1987-10-19 1991-07-30 Ppg Industries, Inc. Active agent delivery device
US5505963A (en) * 1993-04-07 1996-04-09 Schwartz Pharma Ag Slow release pharmaceutical preparation
GB9711032D0 (en) * 1997-05-30 1997-07-23 Johnson Matthey Plc Compound as a stimulant for the central nervous system
WO2001017528A1 (en) * 1999-09-08 2001-03-15 Nitromed, Inc. Methods of treating and preventing congestive heart failure with hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate
US7708989B2 (en) * 1999-10-29 2010-05-04 Nitromed, Inc. Methods of treating vascular diseases characterized by nitric oxide insufficiency
AU780261B2 (en) * 1999-10-29 2005-03-10 Nitromed, Inc. Methods of treating vascular diseases characterized by nitric oxide insufficiency
US7537785B2 (en) * 1999-10-29 2009-05-26 Nitromed, Inc. Composition for treating vascular diseases characterized by nitric oxide insufficiency
US7235237B2 (en) * 1999-10-29 2007-06-26 Nitromed, Inc. Methods of treating vascular diseases characterized by nitric oxide insufficiency
US6479060B1 (en) 2001-09-04 2002-11-12 Healthpoint, Ltd. Elegant hydrogenated castor oil ointments
US7439241B2 (en) * 2003-05-27 2008-10-21 Galderma Laboratories, Inc. Compounds, formulations, and methods for treating or preventing rosacea
WO2007097951A2 (en) * 2006-02-17 2007-08-30 Nitromed, Inc. Methods using hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate
EP2024337A4 (de) * 2006-05-16 2011-09-14 Nitromed Inc Feste dosierungsformulierungen von hydralazinverbindungen
US8496917B2 (en) * 2009-11-13 2013-07-30 Sytheon Ltd Compositions and methods for improving skin appearance
WO2016160635A1 (en) 2015-03-27 2016-10-06 Sytheon Limited Compositions and methods for treating psoriasis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA715659B (en) * 1970-10-02 1972-04-26 Syntex Corp Fatty-alcohol propylene glycol cosolvent vehicle
BE790136R (fr) * 1971-11-29 1973-02-15 Esteve Labor Dr Nouveaux esters et hemi-esters des acides dicarboxyliques et procede depreparation de ces
FR2379285A2 (fr) * 1977-02-08 1978-09-01 Expl Marques Brevets Et Nouvelle composition a base d'acide salicylique et de corticoide
US4112115A (en) * 1976-11-08 1978-09-05 Coghlan Charles C Therapy of leg muscle cramps

Also Published As

Publication number Publication date
IT8019266A0 (it) 1980-01-17
ATA809079A (de) 1981-06-15
AU5445880A (en) 1980-12-18
JPS55167216A (en) 1980-12-26
IE49527B1 (en) 1985-10-16
SE442266B (sv) 1985-12-16
LU81902A1 (de) 1980-04-22
DE2924005A1 (de) 1980-12-18
SE8001599L (sv) 1980-12-14
IE800406L (en) 1980-12-13
NL8000129A (nl) 1980-12-16
PT70696A (en) 1980-02-01
ZA796256B (en) 1980-10-29
DE2924005C2 (de) 1984-07-05
AT365451B (de) 1982-01-25
CH643456A5 (de) 1984-06-15
AR222527A1 (es) 1981-05-29
BE881382A (fr) 1980-05-16
DK528879A (da) 1980-12-14
FR2458285A1 (fr) 1981-01-02
NO801710L (no) 1980-12-15
FI69753B (fi) 1985-12-31
IT1140521B (it) 1986-10-01
US4293565A (en) 1981-10-06
CA1118351A (en) 1982-02-16
FR2458285B1 (de) 1983-04-22
ES8100883A1 (es) 1981-03-01
GB2050827A (en) 1981-01-14
AU530739B2 (en) 1983-07-28
GR70373B (de) 1982-09-30
FI794003A (fi) 1980-12-14
YU308379A (en) 1988-04-30
GB2050827B (en) 1983-04-20
ES487833A0 (es) 1980-12-16
JPS6321648B2 (de) 1988-05-09

Similar Documents

Publication Publication Date Title
FI69753C (fi) Foerfarande foer framstaellning av en salva pao basis av isosorbiddinitrat
EP2191827B1 (de) Antimykotische zusammensetzung
KR101089049B1 (ko) 친지성 약물의 제형
KR100303095B1 (ko) 알릴 아민 화합물을 함유하는 국소용 약학 조성물
EP1281398B1 (de) Dermale zusammenstellungen die als wirkstoff coenzym q enthalten
WO1993000106A1 (fr) Preparation a usage externe contenant de la cyclosporine
CN110464702A (zh) 一种克立硼罗的软膏剂及其制备方法
AU2004285335B2 (en) Transdermal pharmaceutical spray formulations comprising a VP/VA copolymer and a non-aqueous vehicle
WO1992016237A1 (fr) Composition soulageant les irritations cutanees et preparation pour administration percutanee a usage externe contenant ladite composition
JPH0840880A (ja) 軟ゼラチンカプセル剤中のケトプロフエン溶液に基づく医薬製剤およびその調製法
CN110139641B (zh) 外用组合物
EP0952819B1 (de) Biologisch aktive zusammensetzung
JP6444956B2 (ja) 経皮吸収用組成物
JP2621976B2 (ja) アントラリン・ステロール錯体、その製法および治療・化粧用途
JP6625208B2 (ja) 経皮製剤
AU2008250717A1 (en) Aqueous pharmaceutical preparation
JPH0157091B2 (de)
WO2007086582A1 (ja) ２２－オキサ－１α,２５－ジヒドロキシビタミンＤ3を含有する水中油型乳剤性ローション剤およびそれを用いた皮膚疾患の治療方法
JP2006117539A (ja) 油性軟膏剤
EP4159197A1 (de) Pharmazeutische zubereitung und herstellungsverfahren dafür
RU2148998C1 (ru) Фармацевтическая или ветеринарная композиция (варианты) и способ получения композиции
JP2003073276A (ja) 安定化された抗炎症軟膏剤
JPH10147539A (ja) 外用薬基剤および外用薬

Legal Events

Date Code Title Description
MA Patent expired

Owner name: SANOL SCHWARZ-MONHEIM GMBH